Open Access
Volume 26, 2019
Article Number 49
Number of page(s) 7
Published online 21 August 2019
  1. Baneth G. 2014. Tick-borne infections of animals and humans: a common ground. International Journal for Parasitology, 44, 591–596. [CrossRef] [PubMed] [Google Scholar]
  2. Beugnet F. 2013. Guide to vector borne diseases of pets. Lyon, France: Ed. Merial. p. 425. [Google Scholar]
  3. Beugnet F, Halos L, Larsen D, Labuschagné M, Erasmus H, Fourie J. 2014. The ability of an oral formulation of afoxolaner to block the transmission of Babesia canis by Dermacentor reticulatus ticks to dogs. Parasites & Vectors, 7, 283. [CrossRef] [PubMed] [Google Scholar]
  4. Chomel B. 2011. Tick-borne infections in dogs – an emerging infectious threat. Veterinary Parasitology, 179, 294–301. [CrossRef] [PubMed] [Google Scholar]
  5. Clark IA, Jacobson LS. 1998. Do babesiosis and malaria share a common disease process? Annals of Tropical Medicine and Parasitology, 92, 483–488. [CrossRef] [PubMed] [Google Scholar]
  6. Dantas-Torres F, Otranto D. 2016. Best practices for preventing vector-borne diseases in dogs and humans. Trends in Parasitology, 32, 43–55. [CrossRef] [PubMed] [Google Scholar]
  7. Dumont P, Blair J, Fourie J, Chester TS, Larsen D. 2014. Evaluation of the efficacy of Afoxolaner against two European dog tick species: Dermacentor reticulatus and Ixodes ricinus. Veterinary Parasitology, 201, 216–219. [CrossRef] [PubMed] [Google Scholar]
  8. Fourie JJ, Stanneck D, Jongejan F. 2013. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated with an imidacloprid/flumethrin collar. Veterinary Parasitology, 192, 273–278. [CrossRef] [PubMed] [Google Scholar]
  9. Geurden T, Six R, Becskei C, Maeder S, Lloyd A, Mahabir S, Fourie J, Liebenberg J. 2017. Evaluation of the efficacy of sarolaner (Simparica®) in the prevention of babesiosis in dogs. Parasites & Vectors, 10(1), 415. [CrossRef] [PubMed] [Google Scholar]
  10. Halos L, Baneth G, Beugnet F, Bowman AS, Chomel B, Farkas R, Franc M, Guillot J, Inokuma H, Kaufman R, Jongejan F, Joachim A, Otranto D, Pfister K, Pollmeier M, Sainz A, Wall R. 2012. Defining the concept of “tick repellency” in veterinary medicine. Parasitology, 139, 419–423. [CrossRef] [PubMed] [Google Scholar]
  11. Jacobson LS. 2006. The South African form of severe and complicated canine babesiosis: clinical advances 1994–2004. Veterinary Parasitology, 138, 126–139. [CrossRef] [PubMed] [Google Scholar]
  12. Jongejan F, Fourie JJ, Chester ST, Manavella C, Mallouk Y, Pollmeier MG, Baggott D. 2011. The prevention of transmission of Babesia canis canis by Dermacentor reticulatus tick to dogs using a novel combination of fipronil, amitraz and (S)-methoprene. Veterinary Parasitology, 179, 343–350. [CrossRef] [PubMed] [Google Scholar]
  13. Jongejan F, de Vos C, Fourie JJ, Beugnet F. 2015. A novel combination of fipronil and permethrin (Frontline Tri-Act®/Frontect®) reduces risk of transmission of Babesia canis by Dermacentor reticulatus and of Ehrlichia canis by Rhipicephalus sanguineus ticks to dogs. Parasites & Vectors, 8, 602. [CrossRef] [PubMed] [Google Scholar]
  14. Kidd L, Breitschwerdt EB. 2003. Transmission times and prevention of tick-borne diseases in dogs. Compendium on Continuing Education for Practitioner Veterinarians, 10, 742–751. [Google Scholar]
  15. Lavan R, Tunceli K, de Swardt H, Chelchinskey C, Abatzidis M, Armstrong R. 2018. Canine babesiosis treatment rates in South African veterinary clinics between 2011 and 2016. Parasites & Vectors, 11, 386. [CrossRef] [PubMed] [Google Scholar]
  16. Marchiondo AA, Holdsworth PA, Fourie LJ, Rugg D, Hellmann K, Snyder DE, Dryden MW. 2013. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats. Veterinary Parasitology, 194, 84–97. [CrossRef] [PubMed] [Google Scholar]
  17. Mehlhorn H, Schein E, Voigt WP. 1980. Light and electron microscopic study on developmental stages of Babesia canis within the gut of the tick Dermacentor reticulatus. Journal of Parasitology, 66, 220–228. [CrossRef] [Google Scholar]
  18. Navarro C, Reymond N, Fourie J, Hellmann K, Bonneau S. 2015. Prevention of Babesia canis in dogs: efficacy of a fixed combination of permethrin and fipronil (Effitix®) using an experimental transmission blocking model with infected Dermacentor reticulatus ticks. Parasites & Vectors, 8, 32. [CrossRef] [PubMed] [Google Scholar]
  19. Otranto D. 2018. Arthropod-borne pathogens of dogs and cats: From pathways and times of transmission to disease control. Veterinary Parasitology, 251, 68–77. [CrossRef] [PubMed] [Google Scholar]
  20. Otranto D, Wall R. 2008. New strategies for the control of arthropod vectors of disease in dogs and cats. Medical Veterinary and Entomology, 22, 291–302. [CrossRef] [Google Scholar]
  21. Penzhorn BL. 2011. Why is Southern African canine babesiosis so virulent? An evolutionary perspective Parasites & Vectors, 4, 51. [CrossRef] [PubMed] [Google Scholar]
  22. Penzhorn BL, Vorster I, Harrison-White RF, Oosthuizen MC. 2017. Black-backed jackals (Canis mesomelas) are natural hosts of Babesia rossi, the virulent causative agent of canine babesiosis in sub-Saharan Africa. Parasites & Vectors, 10, 124. [CrossRef] [PubMed] [Google Scholar]
  23. Piesman J. 1995. Dispersal of the Lyme disease spirochete Borrelia burgdoferi to salivary glands of feeding nymphal Ixodes scapularis (Acari: Ixodidae). Journal of Medical Entomology, 32, 519–521. [CrossRef] [PubMed] [Google Scholar]
  24. Shoop WL, Hartline E, Gould B, Waddell M, McDowell R, Kinney J, Lahm G, Long J, Xu M, Wagerle T, Jones G, Dietrich R, Cordova D, Schroeder M, Rhoades D, Benner E, Confalone P. 2014. Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs. Veterinary Parasitology, 201, 179–189. [CrossRef] [PubMed] [Google Scholar]
  25. Taenzler J, Liebenberg J, Roepke RK, Heckeroth AR. 2015. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™). Parasites & Vectors, 8, 305. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.